Lifang Song

发表

A uniform quantitative enzyme-linked immunosorbent assay for Coxsackievirus A16 antigen in vaccine

Xing Wu, T. Cheng, Zhenglun Liang, 2020, Human vaccines & immunotherapeutics.

Heterologous immunization with adenovirus vectored and inactivated vaccines effectively protects against SARS-CoV-2 variants in mice and macaques

Xing Wu, Jincun Zhao, Changgui Li, 2022, Frontiers in Immunology.

Construction and verification of an infectious cDNA clone of coxsackievirus B5

Jialu Zhang, Zhenglun Liang, Dongming Liu, 2022, Virologica Sinica.

Heterologous Omicron-adapted vaccine as a secondary booster promotes neutralizing antibodies against Omicron and its sub-lineages in mice

Zhenglun Liang, Dongming Liu, Fan Gao, 2022, Emerging microbes & infections.

Establishment of the first Chinese national standard for protein subunit SARS-CoV-2 vaccine

Changgui Li, Zhenglun Liang, K. Xu, 2022, Vaccine.

A Short 5′triphosphate RNA nCoV-L Induces a Broad-Spectrum Antiviral Response by Activating RIG-I

Xing Wu, Zhenglun Liang, Xiuling Li, 2022, Viruses.

Advances in COVID-19 mRNA vaccine development

Yuhua Li, Jingjing Liu, Xiaohong Wu, 2022, Signal Transduction and Targeted Therapy.

Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine

Xing Wu, Jialu Zhang, Changgui Li, 2021, Emerging microbes & infections.

A Novel Single-Stranded RNA-Based Adjuvant Improves the Immunogenicity of the SARS-CoV-2 Recombinant Protein Vaccine

Zhenglun Liang, Dongming Liu, Q. Mao, 2022, Viruses.

Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitors

Xing Wu, Zhenglun Liang, Dongming Liu, 2023, Signal transduction and targeted therapy.

Transcriptomic analysis of the innate immune signatures of a SARS-CoV-2 protein subunit vaccine ZF2001 and an mRNA vaccine RRV

Zhenglun Liang, Dongming Liu, Miao Xu, 2022, Emerging microbes & infections.